We are delighted to have Hardy Diagnostics distribute the rapid and affordable CDx pathogen detection Xpress System throughout North America.
Broomfield, CO / Santa Maria, CA (PRWEB) January 19, 2016
Crystal Diagnostics (CDx) announced today that it has signed an agreement with Hardy Diagnostics to sell and distribute in North America the CDx Xpress System -- a rapid and sensitive pathogen detection platform.
This agreement adds an equipment line to Hardy’s dominant position in food safety testing reagents and proprietary enrichment media. Hardy Corporate Vice President, Christopher Catani said, “Distribution rights for the unique CDx detection system clearly demonstrate the Hardy commitment to bringing the most advanced, fastest, and most accurate diagnostic system to our customers."
According to CDx President and CEO Jim Bruce, “Hardy is recognized in the Food Safety sector as a distributor of high quality test reagents and we are delighted to have our rapid and affordable system available throughout North America. We believe this will be a “win-win” for our companies and our clients.”
In the past twelve months Crystal Diagnostics has sold Xpress Systems to a number of processors, government and commercial test labs, as well as academic and research organizations. The system has numerous AOAC accreditations, including E. coli O157 and the “Big 6” STECs.
The company expects accreditations for Salmonella and Listeria by the end of the first quarter 2016.
Crystal Diagnostics was founded in 2006 and is the exclusive licensee of fundamental liquid crystal technologies developed through a research partnership between Kent State University and Northeast Ohio Medical University. For more information about the company or its Xpress Pathogen Detection System, visit http://www.crystaldiagnostics.com or contact CEO Jim Bruce at 720-351-4885.
About Hardy Diagnostics:
Hardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. Hardy Diagnostics was founded in 1980 in Santa Barbara by Jay Hardy and Robert Shibata after they completed their Medical Technology training in the laboratory at Santa Barbara Cottage Hospital. Hardy Diagnostics manufactures over 2,700 different products for the culture and identification of bacteria and fungi. Among its offerings are products used to culture and detect pathogens commonly reported in the news, such as E. coli, Salmonella, Listeria, MRSA, and Influenza. In addition, the company manufactures reagents and media for use by molecular biology researchers. Over 9,000 laboratories throughout the nation rely on Hardy Diagnostics for their supplies.
Today, Hardy Diagnostics employs over 300 people and maintains nine distribution centers throughout the U.S. Manufacturing takes place at its headquarters in Santa Maria, California and at a recently opened facility in Springboro, Ohio. The company also exports products through over 65 foreign distributors. The company’s mission is to “partner with its laboratory customers to prevent and diagnose disease.” For more information, visit http://www.HardyDiagnostics.com